# $acet

Adicet Bio announces promising early-stage data for its lead cancer therapy candidate, potentially signaling a breakthrough in solid tumor treatment. The company's stock sees a modest uptick on the news, with investors closely watching for further clinical developments.

### About $acet
Adicet Bio is a biotechnology company focused on developing innovative cell therapies for a range of diseases.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing